Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : DRKOOP.Com,Inc - (Nasdaq - KOOP) -- Ignore unavailable to you. Want to Upgrade?

To: ezzy e who wrote (272)	6/28/1999 9:49:00 AM
From: yzfool	Respond to of 595

Alliance with QTRN announced for providing access to clinical trials through KOOP's website. Clinical trials are the main bottleneck for pharmaceutical companies to obtain FDA approval. Clinical trials are also an alternative form of therapy available to qualifying individuals. KOOP once again has added value to this property and managed to place it on pharmaceutical sector radar screens. LONG recommendation

To: ezzy e who wrote (272)	6/28/1999 11:28:00 AM
From: PartyTime	Read Replies (1) \| Respond to of 595

Ezzy--I'm no psychic so I don't know what KOOP's stock price will be by the end of July. I'm confident it'll be higher than present. My guess is KOOP will fluctuate for a while in a trading range of 15 to 20. I also think KOOP has potential to become one of those stocks which rise double digits in a single day. I'm convinced that KOOP is destined as a premier leader in the Internet health care industry. I stated earlier that I became an advocate of KOOP not as an investor, but rather as one who visited the website for medical information. It was helpful and informative for me then so I bookmarked it and subscribed to its medical updates. I didn't buy into the IPO, I bought my shares--with a long-term perspective--about an hour before Dr. Koop made his IPO-day appearance on CNBC. Prior to that I had been investing in oil patch stocks, but I felt KOOP had a greater rise capacity both short and long-term. I hope to do well. Good luck to all!